Biocon Biologics to Present at the 43rd Annual J.P. Morgan Healthcare Conference
BRIDGEWATER, N.J., and BENGALURU, India, Jan. 9, 2025 /PRNewswire/ -- Biocon Biologics Ltd (BBL), a fully integrated global biosimilars company and subsidiary of Biocon Ltd (BSE code: 532523, NSE: BIOCON),